| Original language | English |
|---|---|
| Pages (from-to) | 780-781 |
| Number of pages | 2 |
| Journal | Annals of Oncology |
| Volume | 29 |
| Issue number | 3 |
| DOIs | |
| Publication status | Published - Mar 1 2018 |
Fingerprint
All Science Journal Classification (ASJC) codes
- Hematology
- Oncology
Cite this
Development of leptomeningeal carcinomatosis during a marked response of brain metastases to pembrolizumab in a patient with non-small-cell lung cancer. / Otsubo, K.; Seki, N.; Nakanishi, Y.; Okamoto, I.
In: Annals of Oncology, Vol. 29, No. 3, 01.03.2018, p. 780-781.Research output: Contribution to journal › Letter
}
TY - JOUR
T1 - Development of leptomeningeal carcinomatosis during a marked response of brain metastases to pembrolizumab in a patient with non-small-cell lung cancer
AU - Otsubo, K.
AU - Seki, N.
AU - Nakanishi, Y.
AU - Okamoto, I.
PY - 2018/3/1
Y1 - 2018/3/1
UR - http://www.scopus.com/inward/record.url?scp=85046087105&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85046087105&partnerID=8YFLogxK
U2 - 10.1093/annonc/mdx700
DO - 10.1093/annonc/mdx700
M3 - Letter
C2 - 29088405
AN - SCOPUS:85046087105
VL - 29
SP - 780
EP - 781
JO - Annals of Oncology
JF - Annals of Oncology
SN - 0923-7534
IS - 3
ER -